Relationship of central choroidal thickness with age-related macular degeneration status.

PURPOSE To compare choroidal thickness in patients with intermediate or advanced age-related macular degeneration (AMD) and control subjects using enhanced-depth imaging optical coherence tomography (EDI-OCT). DESIGN Retrospective cross-sectional study of 325 eyes from 164 subjects who underwent EDI-OCT for the Age-Related Eye Disease Study (AREDS) 2 Ancillary Spectral Domain OCT study. METHODS Choroidal thickness was measured by semi-automated segmentation of EDI-OCT images from 1.5 mm nasal to 1.5 mm temporal to the fovea. Multivariate linear regression was used to evaluate the association of subfoveal choroidal thickness or average choroidal thickness across the central 3-mm segment with systemic and ocular variables. Choroidal thickness measurements were compared between eyes with no AMD (n = 154) (ie, controls), intermediate AMD (n = 109), and advanced AMD (n = 62). RESULTS Both subfoveal and average choroidal thicknesses were associated with age (P < .001) and refractive error (P < .001), but not other variables tested. Mean average choroidal thickness was significantly reduced in advanced AMD as compared with control eyes (P = .008), with no significant difference between advanced and intermediate AMD eyes (P = .152) or between intermediate AMD and control eyes (P = .098). Choroidal thinning was also noted from 1.5 mm nasal to 1.5 mm temporal to the fovea when comparing advanced AMD with control eyes (P < .05 at all 0.5 mm interval locations). After adjustment for age and refractive error, however, there was no significant difference in subfoveal (P = .675) or average choroidal thickness (P = .746) across all 3 groups. CONCLUSIONS When adjusted for age and refractive error, central choroidal thickness may not be significantly influenced by AMD status based on AREDS categorization.

[1]  Jost B Jonas,et al.  CHOROIDAL THICKNESS IN AGE-RELATED MACULAR DEGENERATION , 2014, Retina.

[2]  J. Duker,et al.  Analysis of choroidal thickness in age-related macular degeneration using spectral-domain optical coherence tomography. , 2011, American journal of ophthalmology.

[3]  Cynthia A Toth,et al.  Spectral-domain optical coherence tomography characteristics of intermediate age-related macular degeneration. , 2013, Ophthalmology.

[4]  Kaivon L Pakzad-Vaezi,et al.  OPTICAL COHERENCE TOMOGRAPHY–BASED CORRELATION BETWEEN CHOROIDAL THICKNESS AND DRUSEN LOAD IN DRY AGE-RELATED MACULAR DEGENERATION , 2013, Retina.

[5]  G. Ying,et al.  Reduced foveolar choroidal blood flow in eyes with increasing AMD severity. , 2005, Investigative ophthalmology & visual science.

[6]  J. Y. Lee,et al.  Correlation between subfoveal choroidal thickness and the severity or progression of nonexudative age-related macular degeneration. , 2013, Investigative ophthalmology & visual science.

[7]  J. Duker,et al.  Analysis of short-term change in subfoveal choroidal thickness in eyes with age-related macular degeneration using optical coherence tomography. , 2014, Ophthalmic surgery, lasers & imaging retina.

[8]  J. Slakter,et al.  Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. , 2009, American journal of ophthalmology.

[9]  E. Friedman A hemodynamic model of the pathogenesis of age-related macular degeneration. , 1997, American journal of ophthalmology.

[10]  Joseph A. Izatt,et al.  Automatic segmentation of seven retinal layers in SDOCT images congruent with expert manual segmentation , 2010, Optics express.

[11]  Wolfgang Drexler,et al.  Retinal and choroidal thickness in early age-related macular degeneration. , 2011, American journal of ophthalmology.

[12]  G. Ying,et al.  Association of risk factors for choroidal neovascularization in age-related macular degeneration with decreased foveolar choroidal circulation. , 2010, American journal of ophthalmology.

[13]  K. Nishida,et al.  Circadian changes in subfoveal choroidal thickness and the relationship with circulatory factors in healthy subjects. , 2012, Investigative ophthalmology & visual science.

[14]  A. Merkur,et al.  EXACERBATION OF CHOROIDAL AND RETINAL PIGMENT EPITHELIAL ATROPHY AFTER ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION , 2014, Retina.

[15]  E. Sigler,et al.  Comparison of macular choroidal thickness among patients older than age 65 with early atrophic age-related macular degeneration and normals. , 2013, Investigative ophthalmology & visual science.

[16]  R. Spaide,et al.  Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. , 2010, Ophthalmology.

[17]  Sina Farsiu,et al.  Dry age-related macular degeneration: mechanisms, therapeutic targets, and imaging. , 2013, Investigative ophthalmology & visual science.

[18]  Akio Oishi,et al.  Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy. , 2012, Investigative ophthalmology & visual science.

[19]  Stefanie G. Schuman,et al.  Spatial correlation between hyperpigmentary changes on color fundus photography and hyperreflective foci on SDOCT in intermediate AMD. , 2012, Investigative ophthalmology & visual science.

[20]  Srinivas R Sadda,et al.  Spatial distribution of posterior pole choroidal thickness by spectral domain optical coherence tomography. , 2011, Investigative ophthalmology & visual science.

[21]  Eric L Yuan,et al.  Quantitative classification of eyes with and without intermediate age-related macular degeneration using optical coherence tomography. , 2014, Ophthalmology.

[22]  J. Duker,et al.  Effect of intravitreous anti-vascular endothelial growth factor therapy on choroidal thickness in neovascular age-related macular degeneration using spectral-domain optical coherence tomography. , 2013, JAMA ophthalmology.

[23]  R. Spaide,et al.  Enhanced depth imaging spectral-domain optical coherence tomography. , 2008, American journal of ophthalmology.

[24]  Se Woong Kang,et al.  Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. , 2011, Ophthalmology.

[25]  Sina Farsiu,et al.  Validated automatic segmentation of AMD pathology including drusen and geographic atrophy in SD-OCT images. , 2012, Investigative ophthalmology & visual science.

[26]  M. Abràmoff,et al.  Structural and biochemical analyses of choroidal thickness in human donor eyes. , 2014, Investigative ophthalmology & visual science.

[27]  Sina Farsiu,et al.  Characterization of the choroid-scleral junction and suprachoroidal layer in healthy individuals on enhanced-depth imaging optical coherence tomography. , 2014, JAMA ophthalmology.

[28]  Amitha Domalpally,et al.  The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1). , 2012, Ophthalmology.

[29]  Sina Farsiu,et al.  Effect of anti-vascular endothelial growth factor therapy on choroidal thickness in diabetic macular edema. , 2014, American journal of ophthalmology.

[30]  Takayuki Baba,et al.  Relationship between RPE and choriocapillaris in age-related macular degeneration. , 2009, Investigative ophthalmology & visual science.

[31]  Soon-Sun Kwon,et al.  COMPARISON OF CHOROIDAL THICKNESS AMONG PATIENTS WITH HEALTHY EYES, EARLY AGE-RELATED MACULOPATHY, NEOVASCULAR AGE-RELATED MACULAR DEGENERATION, CENTRAL SEROUS CHORIORETINOPATHY, AND POLYPOIDAL CHOROIDAL VASCULOPATHY , 2011, Retina.

[32]  P T de Jong,et al.  Morphometric analysis of Bruch's membrane, the choriocapillaris, and the choroid in aging. , 1994, Investigative ophthalmology & visual science.

[33]  Magali Saint-Geniez,et al.  An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris , 2009, Proceedings of the National Academy of Sciences.

[34]  Cynthia A. Toth,et al.  Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. , 2013, JAMA.

[35]  S. Sadda,et al.  Diurnal variation of choroidal thickness in normal, healthy subjects measured by spectral domain optical coherence tomography. , 2012, Investigative ophthalmology & visual science.

[36]  J. Duker,et al.  ANALYSIS OF THE THICKNESS AND VASCULAR LAYERS OF THE CHOROID IN EYES WITH GEOGRAPHIC ATROPHY USING SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY , 2014, Retina.

[37]  A. Yoshida,et al.  Relationship between choroidal thickness and choroidal circulation in healthy young subjects. , 2012, American journal of ophthalmology-glaucoma.

[38]  E. Aguilar,et al.  Targeted deletion of Vegfa in adult mice induces vision loss. , 2012, The Journal of clinical investigation.

[39]  A. Loewenstein,et al.  Enhanced depth imaging optical coherence tomography: choroidal thickness and correlations with age, refractive error, and axial length. , 2012, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

[40]  Min Kim,et al.  Association between choroidal thickness and ocular perfusion pressure in young, healthy subjects: enhanced depth imaging optical coherence tomography study. , 2012, Investigative ophthalmology & visual science.

[41]  Y. Tano,et al.  Retinal and choroidal biometry in highly myopic eyes with spectral-domain optical coherence tomography. , 2009, Investigative ophthalmology & visual science.

[42]  A. Ho,et al.  Foveolar choroidal blood flow in age-related macular degeneration. , 1998, Investigative ophthalmology & visual science.

[43]  Robert F Mullins,et al.  Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration. , 2011, Investigative ophthalmology & visual science.

[44]  Hyo Kyung Lee,et al.  Comparison of Choroidal Thickness in Patients with Diabetes by Spectral-domain Optical Coherence Tomography , 2013, Korean journal of ophthalmology : KJO.

[45]  R. Spaide,et al.  A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. , 2009, American journal of ophthalmology.

[46]  Hideki Koizumi,et al.  Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month results. , 2012, Ophthalmology.